Office Bearers

Dr Stephen M. Philcox
President
Dr Stephen M. Philcox

Gastroenterologist and interventional endoscopist
The John Hunter Hospital
Dr Philcox is a gastroenterologist and interventional endoscopist who has been working at John Hunter Hospital since 2010 following a fellowship in interventional endoscopy at Duke University. His practice encompasses therapeutic EUS and ERCP and he has a special interest in all things pancreatic.


Dr Marina Pajic
Councillor
Dr Marina Pajic

Personalised Cancer Therapeutics
Cancer Division
Garvan Institute of Medical Research
Research Interests: Testing and validation of novel druggable targets and therapeutic regimens in early development for the treatment of pancreatic cancer. Development and characterisation of novel, robust preclinical models of pancreatic cancer as a platform for comprehensive pre-clinical screening. Discovery of prognostic biomarkers and clinically useful biomarker-guided treatment combinations for pancreatic cancer.


Dr Ilse Rooman
Councillor
Mr Daniel Croagh MBBS PhD FRACS

HPB Surgeon
Lecturer in Surgery
Monash Medical Centre, Monash
Department of Surgery
Monash Gastrointestinal Specialists
Mr Dan Croagh is a hepatobiliary and pancreatic surgeon working predominantly at Monash Medical Centre. He obtained a PhD in stem cell biology at Peter MacCallum Cancer Centre in 2007. He had Fellowship training at Monash Medical Centre, Melbourne and the Liver Transplant Unit at the Queen Elizabeth Hospital in Birmingham, UK. His areas of special interest include hepatobiliary endoscopy (endoscopic ultrasound and ERCP), complex liver and pancreatic surgery for benign and malignant conditions, gall stone disease and severe pancreatitis.


Professor Minoti Apte

Councillor
Professor Minoti Apte, OAM

MBBS (Hons), MMedSci, PhD
Professor of Medicine and Director, Pancreatic Research Group
South Western Sydney Clinical School, UNSW Sydney and Ingham Institute for Applied Medical Research
Research interests: Pathogenesis of chronic pancreatitis and pancreatic cancer with particular reference to the extensive fibrosis of both diseases. Pioneering work in pancreatic stellate cell (PSC) biology and the role of PSCs in pancreatic fibrogenesis. In vivo models include a rat model of alcohol and smoking-related pancreatitis and an orthotopic mouse model of pancreatic cancer. In vitro work involves cultured human and rodent pancreatic stellate cells, rat pancreatic acinar and duct cells and human pancreatic cancer cells. Research aims to develop novel strategies to inhibit pancreatic fibrosis and interrupt stromal-tumour interactions to improve outcomes for patients with chronic pancreatitis and pancreatic cancer.


Dr. Anubhav Mittal
Councillor
Dr. Anubhav Mittal

Dr. Mittal provides general surgical and specialist pancreatic surgical care at Royal North Shore Hospital, North Shore Private Hospital, Ryde Hospital, Macquarie University Hospital and Norwest Private Hospital. He maintains an active research interest in pancreatic cancer and acute pancreatitis


A/Prof Nam Q. Nguyen
Councillor
A/Prof Nam Q. Nguyen

Senior Consultant Gastroenterologist
Interventional & EUS endoscopist
Department of Gastroenterology
Royal Adelaide Hospital

Dr Nguyen is the Senior Consultant Gastroenterologist at the Royal Adelaide Hospital, and a Associate Professor the University of Adelaide. He is an Interventional Endoscopist, who had spent two dedicated years of fellowship in United States to train in advanced endoscopy and management of hepatobiliary disorders. At a research level, he is actively involved in a number of national and international projects that aims to advance our understanding in the genetics of pancreatic cancer and treatment. He also facilitates the screening program for subjects who are at risk of pancreatic cancer.


Immediate past president
A/Prof Mehrdad Nikfarjam

MD, PhD, FRACS
Liver, Pancreatic and Biliary Surgeon
University of Melbourne
Research interests:
Clinical research: Advanced and minimally invasive pancreatic resection techniques. Borderline resectable pancreatic cancers. Neoadjuvant and adjuvant chemotherapy trials. Enhanced post -operative recovery techniques. Fluid sparing therapies in pancreatic surgery. Familial pancreatic cancer screening.
Basic Research: Mouse models of pancreatic cancer. K-ras targeted therapies. Role of P-21 Kinase in the development and progression of pancreatic cancer.